Deal overview

Deal overview
Target UPJOHN INC
Bidder MYLAN NV
Price £60.00 Full version or £25.00 Light version
Publication Date Jul 29, 2019
Abstract On 29 July 2019, it was announced that the Dutch registered, Nasdaq listed, pharmaceuticals company Mylan NV was to acquire Upjohn Inc, the generic medicines business of the quoted US pharmaceuticals group, Pfizer Inc. The combination would be effected using an all-stock Reverse Morris Trust mechanism whereby Upjohn would be spun off or split off to Pfizer shareholders and ...
Number of pages (Full version) 6
Number of pages (Light version) 2
Format Adobe Acrobat (Download Acrobat Reader)
Free Sample Click Here to Download

Purchase this report

Accepted credit cards: Visa, America Express, Master Card

Buy and download this report in a fast a safe way using our secure payment system. We accept all major credit cards.

Search for Deals

Search over 70 million deal reports on more than 550,000 public and private companies. (copy)

Back to search results

Page Time: 0.029074s